Cargando…
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells
BACKGROUND: Triple-negative breast cancer (TNBC) is the most heterogeneous and malignant subtype of breast cancer (BC). TNBC is defined by the absence of expression of estrogen, progesterone and HER2 receptors and lacks efficacious targeted therapies. NEK2 is an oncogenic kinase that is significantl...
Autores principales: | Naro, Chiara, De Musso, Monica, Delle Monache, Francesca, Panzeri, Valentina, de la Grange, Pierre, Sette, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686545/ https://www.ncbi.nlm.nih.gov/pubmed/34930366 http://dx.doi.org/10.1186/s13046-021-02210-3 |
Ejemplares similares
-
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer
por: Naro, Chiara, et al.
Publicado: (2022) -
The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival
por: Naro, Chiara, et al.
Publicado: (2014) -
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019) -
CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1
por: Panzeri, Valentina, et al.
Publicado: (2023) -
RBFOX2 and alternative splicing in B-cell lymphoma
por: Quentmeier, Hilmar, et al.
Publicado: (2018)